Zinc was discovered to be a novel second messenger in immunoreactive cells. We synthesized a novel free
zinc chelator, IPZ-010. Here, we investigated the effects of IPZ-010 in a mouse postoperative
ileus model and determined the effects of
zinc signal inhibition as a new therapeutic strategy against postoperative
ileus.
Zinc waves were measured in bone marrow-derived mast cells (BMMCs) loaded with a
zinc indicator, Newport green. Degranulation and
cytokine expression were measured in BMMCs and bone marrow-derived macrophages (BMDMs). Postoperative
ileus model mice were established with intestinal manipulation. Mice were treated with IPZ-010 (30 mg/kg, s.c. or p.o.) 1 h before and 2 h and 4 h after intestinal manipulation. Gastrointestinal transit, inflammatory cell infiltration, and expression of inflammatory mediators were measured. Free
zinc waves occurred following
antigen stimulation in BMMCs and were blocked by IPZ-010. IPZ-010 inhibited
interleukin-6 secretion and degranulation in BMMCs. IPZ-010 inhibited
tumor necrosis factor-α
mRNA expression in BMMCs stimulated with
lipopolysaccharide or
adenosine triphosphate, whereas IPZ-010 had no effects on
tumor necrosis factor-α
mRNA expression in BMDMs stimulated with
lipopolysaccharide or
adenosine triphosphate. In postoperative
ileus model mice, IPZ-010 inhibited leukocyte infiltration and
cytokine expression, which ameliorated gastrointestinal transit. Furthermore,
ketotifen (1 mg/kg) induced similar effects as IPZ-010. These effects were not amplified by co-administration of IPZ-010 and
ketotifen. IPZ-010 inhibited
zinc waves, resulting in inhibition of inflammatory responses in activated BMMCs in vitro. Targeting
zinc waves in inflammatory cells may be a novel therapeutic strategy for treating postoperative
ileus.